A Phase II/III ,Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Adaptive Design Study Evaluating the Efficacy And Safety of Mitizodone Phosphate Tablets in the Treatment of Patient With Major Depressive Disorder
Latest Information Update: 07 May 2024
At a glance
- Drugs HEC30654-AcOH (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Sunshine Lake Pharma
- 13 Oct 2021 Planned initiation date changed from 1 Aug 2021 to 1 Nov 2021.
- 03 Aug 2021 New trial record